4.5 Review

Sex and gender issues in multiple sclerosis

Journal

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
Volume 6, Issue 4, Pages 237-248

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1756285613488434

Keywords

Multiple sclerosis; sex; female; pregnancy; genes; immunology

Funding

  1. Novartis
  2. Sanofi-Aventis
  3. Biogen Idec, Norway
  4. Bayer Schering
  5. BiogenIdec
  6. MerckSerono
  7. Sanofi Genzyme
  8. TEVA
  9. Bayer Schering Pharma
  10. EMD Merck Serono
  11. Genzyme
  12. Teva Pharmaceuticals

Ask authors/readers for more resources

Multiple sclerosis (MS) is universally found to be more prevalent in women than men. This has led to extensive studies of differences in the immune system or nervous system between women and men, which might be caused by the effects of gonadal hormones, genetic differences, and different environmental exposures and modern lifestyle in men and women. We review the effects of sex and gender from a genetic, immunological and clinical point of view. We discuss the effects of sex on the clinical expression of MS and responses to therapy, as well as issues concerning pregnancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available